Gurit Buys Chinese Wind Blade Mold Manufacturer

Gurit (SIX Swiss Exchange: GUR), has signed an agreement to acquire Suzhou Red Maple Wind Blade Mould Co. Ltd., Taicang, Jiangsu/China, by taking over the entirety of its parent company Cheer Tech Investment Limited, Hong Kong, from Windy Shore Holdings Limited, British Virgin Islands. The acquisition is expected to be closed before year-end 2009 and will allow Gurit to substantially increase its strategic technology and product offering in the rapidly growing Wind Energy market, especially in Asia.

The Wind Energy market in Asia, and China in particular, continues to grow rapidly. In contrast to the rest of the world, the Chinese wind turbine market uses predominantly infusion technology, and similar blade designs. By signing an agreement to acquire Suzhou Red Maple Wind Blade Mould Co. Ltd, Taicang, Jiangsu/People's Republic of China, Gurit acquires the market leading Chinese producer of wind turbine blade moulds and thus expands its offering to the Wind Energy Market in particular to the infusion technology segment. The transaction is expected to be closed before the end of this year.

Building on its materials manufacturing, composite processing and structural engineering know-how, Gurit will leverage its newly gained position in mould manufacturing first to continue to support the Asian wind turbine blade manufacturers market. Based on quality and economies of scale, Gurit then plans to expand the mould offering globally, supported by its existing worldwide distribution network and composite technology basis.

In the context of this transaction, Gurit will acquire Cheer Tech Investment Limited, Hong Kong, from Windy Shore Holdings Limited, British Virgin Islands. Cheer Tech's only operational holding is Suzhou Red Maple. This company is located in Taicang, Jiangsu/People's Republic of China, and generates with some 500 employees a growing annual sales volume of around CHF 30 million in 2009. The acquisition price is in the range of CHF 40 million consisting of an initial payment and performance based installments over the next three years. The new business will be immediately accretive to Gurit's earnings. With this acquisition, China becomes Gurit's largest manufacturing base worldwide with over 800 people employed in Taicang, Tianjin, and Quingdao.

Suzhou Red Maple's management team led by Gabriel Mironov will continue to run the operation. Mr. Mironov, a Canadian citizen, is appointed General Manager of the new Composite Process Equipment market area.

Rudolf Hadorn, CEO of Gurit, comments this transaction: "With the acquisition of the growing and profitable Red Maple organization, Gurit significantly strengthens its footprint in the Asian growth market, expands its offering to all wind energy customers in Asia and later globally, and gains a strong entrepreneurial group of people around Gabriel Mironov in its organization. We welcome Gabriel and all of Red Maple's employees to Gurit".

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Gurit Inc. (2019, February 10). Gurit Buys Chinese Wind Blade Mold Manufacturer. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=20013.

  • MLA

    Gurit Inc. "Gurit Buys Chinese Wind Blade Mold Manufacturer". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=20013>.

  • Chicago

    Gurit Inc. "Gurit Buys Chinese Wind Blade Mold Manufacturer". AZoM. https://www.azom.com/news.aspx?newsID=20013. (accessed November 21, 2024).

  • Harvard

    Gurit Inc. 2019. Gurit Buys Chinese Wind Blade Mold Manufacturer. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=20013.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.